SAFETY AND PHARMACOKINETICS OF A NOVEL HUMAN MONOCLONAL ANTIBODY DIRECTED AGAINST THE E2 GLYCOPROTEIN OF HEPATITS C VIRUS (MBL-HCV1) IN HEALTHY VOLUNTEERS

被引：2
|
作者：
Leav, B. A. [1 ]
Sloan, S. [1 ]
Blair, B. M. [1 ]
Cheslock, P. [1 ]
Knauber, M. [1 ]
Ambrosino, D. M. [1 ]
Molrine, D. C. [1 ]
机构：
[1] Univ Massachusetts, Sch Med, Boston, MA 02125 USA
来源：
JOURNAL OF HEPATOLOGY | 2010年 / 52卷
关键词：
D O I：
10.1016/S0168-8278(10)60283-8
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：S118 / S118
页数：1
相关论文
共 50 条
  • [41] Human hepatic sinusoidal endothelial cells (HSEC) interact with hepatitis C virus (HCV) E2 glycoprotein via DCSIGN and LSIGN
    Lai, WK
    Sun, PJ
    Zhang, J
    Youster, J
    McKeating, J
    Adams, DH
    JOURNAL OF HEPATOLOGY, 2004, 40 : 119 - 120
  • [42] In vivo combination of human anti-envelope glycoprotein E2 and -Claudin-1 monoclonal antibodies for prevention of hepatitis C virus infection
    Mailly, Laurent
    Wrensch, Florian
    Heydmann, Laura
    Fauvelle, Catherine
    Brignon, Nicolas
    Zeisel, Mirjam B.
    Pessaux, Patrick
    Keck, Zhen-yong
    Schuster, Catherine
    Fuerst, Thomas R.
    Foung, Steven K. H.
    Baumert, Thomas F.
    ANTIVIRAL RESEARCH, 2019, 162 : 136 - 141
  • [43] Human monoclonal antibodies against chikungunya virus target multiple distinct epitopes in the E1 and E2 glycoproteins
    Quiroz, Jose A.
    Malonis, Ryan J.
    Thackray, Larissa B.
    Cohen, Courtney A.
    Pallesen, Jesper
    Jangra, Rohit K.
    Brown, Rebecca S.
    Hofmann, Daniel
    Holtsberg, Frederick W.
    Shulenin, Sergey
    Nyakatura, Elisabeth K.
    Durnell, Lorellin A.
    Rayannavar, Vinayak
    Daily, Johanna P.
    Ward, Andrew B.
    Aman, M. Javad
    Dye, John M.
    Chandran, Kartik
    Diamond, Michael S.
    Kielian, Margaret
    Lai, Jonathan R.
    PLOS PATHOGENS, 2019, 15 (11)
  • [44] Safety, tolerability, pharmacokinetics, and immunogenicity of a human monoclonal antibody targeting the G glycoprotein of henipaviruses in healthy adults: a first-in-human, randomised, controlled, phase 1 study
    Playford, Elliott Geoffrey
    Munro, Trent
    Mahler, Stephen M.
    Elliott, Suzanne
    Gerometta, Michael
    Hoger, Kym L.
    Jones, Martina L.
    Griffin, Paul
    Lynch, Kathleen D.
    Carroll, Heidi
    El Saadi, Debra
    Gilmour, Margaret E.
    Hughes, Benjamin
    Hughes, Karen
    Huang, Edwin
    de Bakker, Christopher
    Klein, Reuben
    Scher, Mark G.
    Smith, Ina L.
    Wang, Lin-Fa
    Lambert, Stephen B.
    Dimitrov, Dimiter S.
    Gray, Peter P.
    Broder, Christopher C.
    LANCET INFECTIOUS DISEASES, 2020, 20 (04): : 445 - 454
  • [45] Phase 1 safety and pharmacokinetic study of chimeric murine-human monoclonal antibody cαStx2 administered intravenously to healthy adult volunteers
    Dowling, TC
    Chavaillaz, PA
    Young, DG
    Melton-Celsa, A
    O'Brien, A
    Thuning-Roberson, C
    Edelman, R
    Tacket, CO
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2005, 49 (05) : 1808 - 1812
  • [46] Recombinant human monoclonal antibodies against different conformational epitopes of the E2 envelope glycoprotein of hepatitis C virus that inhibit its interaction with CD81
    Allander, T
    Drakenberg, K
    Beyene, A
    Rosa, D
    Abrignani, S
    Houghton, M
    Widell, A
    Grillner, L
    Persson, MAA
    JOURNAL OF GENERAL VIROLOGY, 2000, 81 : 2451 - 2459
  • [47] Efficient hepatitis C antigen immunohistological staining in sections of normal, cirrhotic and tumoral liver using a new monoclonal antibody directed against serum-derived HCV E2 glycoproteins
    Galy, Oivier
    Petit, Marie-Anne
    Benjelloun, Soumaya
    Chevallier, Philippe
    Chevallier, Michelle
    Srivatanakul, Petcharin
    Karalak, Anant
    Carreira, Christine
    Lyandrat, Nicole
    Essaid, Abdellah
    Trepo, Christian
    Hainaut, Pierre
    Chemin, Isabelle
    CANCER LETTERS, 2007, 248 (01) : 81 - 88
  • [48] Characterization of four major human B-cell epitopes on the surface of HCV E2 glycoprotein by generation of human monoclonal Fab from phage display antibody librariesis
    Burioni, R
    Bugli, F
    Mancini, N
    Dicampli, C
    Canducci, F
    Gasbarrini, A
    Clementi, M
    GASTROENTEROLOGY, 2001, 120 (05) : A552 - A552
  • [49] Safety, Pharmacokinetics, and Pharmacodynamics Of SAN-300, a Novel Monoclonal Antibody Against Very Late Antigen-1: Results Of a Phase 1 Study In Healthy Volunteers and Patients With Active Rheumatoid Arthritis.
    Inderjeeth, Charles
    Redfern, Andrew
    Huang, Michael
    Hardiman, Yun
    Grant, Theresa
    Fritz, Lawrence C.
    Fuller, David
    Haughey, David
    Totoritis, Mark C.
    ARTHRITIS AND RHEUMATISM, 2013, 65 : S610 - S610
  • [50] Preparation of human single chain Fv antibody against hepatitis C virus E2 protein and its identification in immunohistochemistry
    Yan-Wei Zhong Jun Cheng Gang Wang Shuang-Shuang Shi Li Li Ling-Xia Zhang Ju-Mei Chen Gene Therapy Research Center
    World Journal of Gastroenterology, 2002, 8 (05) : 863 - 867
12345